Epidemiology of the first 100 cases of COVID-19 in Taiwan and its implications on outbreak control.
J Formos Med Assoc
; 119(11): 1601-1607, 2020 Nov.
Article
in English
| MEDLINE | ID: covidwho-640926
ABSTRACT
PURPOSE:
To describe the epidemiology and outcome of the first 100 COVID-19 cases in Taiwan.METHODS:
We included the first 100 patients with laboratory-confirmed SARS-CoV-2 infection in Taiwan. Demographic, clinical, epidemiological and laboratory data were extracted from outbreak investigation reports and medical records.RESULTS:
Illness onset of the 100 patients was during January 11 to March 16, 2020. Twenty-nine (29%) had at least one underlying condition and ten (10%) were asymptomatic. Seventy-one were imported, including four clusters. Twenty-nine were locally-acquired, including four clusters. The median days from onset to report was longer in locally-acquired cases (10 vs 3 days). Three patients died (case fatality rate 3%) and all of them had underlying conditions. As of May 13, 2020, 93 had been discharged in stable condition; the median hospital stay was 30 days (range, 10-79 days).CONCLUSION:
The first 100 cases of COVID-19 in Taiwan showed the persistent threat of imported cases from different countries. Even though sporadic locally-acquired disease has been identified, through contact investigation, isolation, quarantine and implementation of social distancing measures, the epidemic is contained to a manageable level with minimal local transmission.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Communicable Disease Control
/
Disease Outbreaks
/
Coronavirus Infections
/
Communicable Diseases, Emerging
/
Pandemics
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
J Formos Med Assoc
Journal subject:
Medicine
Year:
2020
Document Type:
Article
Affiliation country:
J.jfma.2020.07.015
Similar
MEDLINE
...
LILACS
LIS